Investor Presentaiton slide image

Investor Presentaiton

Eurofins is setting up a global network of clinical genetics laboratories * eurofins Nowadays, Clinical Genetics is a central element in healthcare and Clinical Diagnostics, contributing to every stage of patient care Throughout all three of Eurofins' start-up programs, several large investments in global clinical genetics laboratories have been made, giving Eurofins a unique portfolio of services for cutting-edge applications. • Eurofins, through acquisitions and start-up laboratories, is investing heavily in advanced technologies: EGL Predictive tests for genetic diseases and oncology Side effects/efficacy of drugs • Rare diseases testing Non Invasive Prenatal Testing Personalized medicine offering patients individualized treatment based on their genetic and metabolic profiles Next Generation Sequencing -Whole Genome Sequencing NTD USA Boston Heart Europe Developments in genetics and genomics will have a significant impact on tomorrow's clinical diagnostics market APAC Vira Cor Diatherix Biomnis Megalab Lifecodexx Genoma Clinical Genetics Bangalore start-up Clinical Genetics Tokyo start-up Since 2014, Eurofins has already developed a network of laboratories focused on clinical genetics in several countries around the globe, including: India, Japan, France, Germany, Spain, Italy and the USA 59
View entire presentation